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ABSTRACT: Long INterspersed Element-1 (LINE-1 or
L1) retrotransposons are the only autonomously active
transposable elements in the human genome. The average
human genome contains ∼80–100 active L1s, but only a
subset of these L1s are highly active or ‘hot’. Human L1s
are closely related in sequence, making it difficult to de-
cipher progenitor/offspring relationships using traditional
phylogenetic methods. However, L1 mRNAs can some-
times bypass their own polyadenylation signal and instead
utilize fortuitous polyadenylation signals in 3′ flanking
genomic DNA. Retrotransposition of the resultant mR-
NAs then results in lineage specific sequence “tags” (i.e.,
3′ transductions) that mark the descendants of active L1
progenitors. Here, we developed a method (Transduction-
Specific Amplification Typing of L1 Active Subfamilies or
TS-ATLAS) that exploits L1 3′ transductions to identify
active L1 lineages in a genome-wide context. TS-ATLAS
enabled the characterization of a putative active progeni-
tor of one L1 lineage that includes the disease causing L1
insertion L1RP, and the identification of new retrotranspo-
sition events within two other “hot” L1 lineages. Intrigu-
ingly, the analysis of the newly discovered transduction
lineage members suggests that L1 polyadenylation, even
within a lineage, is highly stochastic. Thus, TS-ATLAS
provides a new tool to explore the dynamics of L1 lineage
evolution and retrotransposon biology.
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Introduction
Long INterspersed Element-1 (LINE-1 or L1) sequences are
autonomously mobile non-LTR retrotransposons that are ubiqui-
tous in mammalian genomes (reviewed in Beck et al. (2011)). In
humans, L1s comprise∼17% of the genome and are responsible for
the genesis of at least another 10%ofDNA through themobilization
of nonautonomous retrotransposons (e.g., Alu and SVA elements),
certain noncoding RNAs, and cellular mRNAs, which leads to the
creation of processed pseudogenes [Buzdin et al., 2002; Bennett
et al., 2004; Dewannieux et al., 2003; Esnault et al., 2000; Garcia-
Perez et al., 2007; Gilbert et al., 2005; Hancks et al., 2011; Lander
et al., 2001; Ostertag et al., 2003; Wei et al., 2001; Weber, 2006].
Despite their prevalence, there is a profound dearth of knowledge
regarding the active L1s segregating in human populations.
In silico studies have been instrumental in identifying active (i.e.,
retrotransposition competent or RC-L1s) human L1 elements. RC-
L1s contain an intact 5′ UTRharboring an internal RNApolymerase
II promoter [Swergold, 1990] that drives transcription of an mRNA
containing two open reading frames (ORF1 andORF2) [Dombroski
et al., 1991; Scott et al., 1987]. The L1-encoded proteins (ORF1p and
ORF2p) are required for retrotransposition [Moran et al., 1996; Feng
et al., 1996] and biochemical and genetic studies indicate that both
proteins preferentially act in cis tomobilize their encoding transcript
[Esnault et al., 2000; Kulpa and Moran, 2006; Wei et al., 2001].
The development of a cultured-cell retrotransposition assay
[Moran et al., 1996] allowed quantification of the retrotranspo-
sition efficiency of individual L1s. In 2003, analysis of the Human
GenomeWorkingDraft (HGWD) sequence [Lander et al., 2001] in-
dicated that 90 L1s had two intact ORFs [Brouha et al., 2003; Myers
et al., 2002]. When 82 of the 90 potential RC-L1s were tested in the
retrotransposition assay, 40 were active [Brouha et al., 2003]. The
majority of these 40 L1s were weakly active; however, six elements,
termed “hot” L1s, displayed robust retrotransposition activity in
HeLa cells [Brouha et al., 2003]. Subsequent genome-wide studies
have indicated that there are significantly more “hot” L1s in the
human population than previously appreciated, and that ongoing
L1 retrotransposition contributes significantly to human genetic di-
versity [Badge et al., 2003; Beck et al., 2010; Ewing and Kazazian,
2010; Huang et al., 2010; Iskow et al., 2010; Kidd et al., 2010; Mills
et al., 2011], reviewed in Beck et al. [2011].
We previously developed a transposon display system (Ampli-
fication Typing of L1 Active Subfamilies or ATLAS) to selectively
amplify human-specific L1 insertions [Badge et al., 2003]. Inter-
estingly, three of seven (∼43%) full-length elements in this study
were “hot” L1s, which contrasts with the relatively low number of
C© 2013 WILEY PERIODICALS, INC.
“hot” L1s in the HGWD [Brouha et al., 2003]. Thus, a combination
of in silico analyses, transposon display approaches, and a cultured
cell retrotransposition assay can identify polymorphic, active L1s
segregating in human populations.
Human-specific L1 subfamilies are evolutionarily young and are
closely related in sequence—for example, the oldest human-specific
L1 subfamily (pre-Ta) originated around 4.4 MYA and its members
are on average 99.4% identical at the nucleotide level [Boissinot
et al., 2000; Marchani et al., 2009]. Thus, it often is difficult to
discern progenitor/offspring relationships among L1s by compar-
ing their sequences. Previous work revealed that the transcription
machinery frequently bypasses the native L1 polyadenylation (poly
(A)) signal and instead terminates at a poly (A) signal in 3′ flanking
genomicDNA[Goodier et al., 2000;Holmes et al., 1994;Moranet al.,
1996, 1999; Pickeral et al., 2000]. The resultant retrotransposition
events therefore acquire a sequence “tag” known as a 3′ transduction
[Goodier et al., 2000; Holmes et al., 1994; Moran et al., 1996, 1999;
Pickeral et al., 2000].
In principle, shared 3′ transductions can be used to identify re-
lated L1s and establish progenitor/offspring relationships. In silico
studies suggest that ∼15% of L1s contain 3′ transductions, and
that 3′ transductions are responsible for generating between 19 and
30.5Mb of human genomic sequence [Goodier et al., 2000; Pickeral
et al., 2000]. Moreover, 3′ transductions have enabled the identi-
fication of putative progenitors of disease-producing L1 insertions
and a number of “hot” L1 lineages [Beck et al., 2010; Brouha et al.,
2002; Goodier et al., 2000; Holmes et al., 1994; Kidd et al., 2010;
Seleme Mdel et al., 2006; Solyom et al., 2012; van den Hurk et al.,
2003, 2007].
Here, we describe a system called Transduction-Specific ATLAS
(TS-ATLAS) that allows the amplification of L1s containing shared
3′ transduced sequences. We report the discovery of new L1s related
to three ‘hot’ L1 lineages: L1RP (AF148856), AC002980, and LRE3
(AC067958) [Brouha et al., 2002; Kimberland et al., 1999; Schwahn
et al., 1998; SelemeMdel et al., 2006]. Notably, we identified a likely
progenitor of a lineage of elements that includes a disease-causing
L1 insertion (L1RP) [Kimberland et al., 1999; Schwahn et al., 1998]
and demonstrated that this L1 is highly active in a cultured human
cell retrotransposition assay. The AC002980 and LRE3 lineages are
extensive (with 10 and eight members, respectively) and generally
are polymorphic. They also have highly variable allele frequencies
(from putatively “Private” insertions present in a single individual
to 0.495), suggesting they have expanded in recent human history.
Within the AC002980 lineage there is evidence for ongoing vari-
ation in poly (A) site selection, suggesting this may be a plastic
feature of L1 evolution. Together, the above data reveal that ongoing
L1 retrotransposition contributes to human genetic diversity and
strongly suggest that these three lineages remain active in human
populations.
Materials and Methods
Identification of L1s Related to AC002980, LRE3, and RP in
Human Genomic Sequence Resources
BLAT searches of the UCSC genome (http://genome.ucsc.edu)
Human March 2006 (NCBI 36/hg18) assembly (hereafter re-
ferred to as the Human Genome Reference, HGR) and BLAST
searches of the NCBI nonredundant nucleotide databases (nr)
(http://www.ncbi.nih.gov) were both performed using AC002980,
LRE3 (Accession Number: AC067958), and L1RP (Accession Num-
ber: AF148856) 3′ transduction sequences as probes [Altschul et al.,
1990; Kent, 2002]. Sequences with >95% identity that were pre-
ceded by an L1HSwere aligned by hand to L1.3 (AccessionNumber:
L19088 [Dombroski et al., 1993]) using the SIMMONIC sequence
analysis package [Simmonds and Smith, 1999] to enable detailed
examination of L1 length and structural hallmarks such as target-
site duplications (TSDs) and poly (A) tails. L1 elements were named
according to the accession number of the sequence into which they
inserted.
TS-ATLAS DNA Samples and Extraction
TS-ATLAS was performed using peripheral blood lymphocyte
and ejaculated sperm derived genomic DNA (gDNA) from nine
healthy, anonymous volunteers, collected with informed consent
under ethical approval from Leicestershire, Northamptonshire, and
RutlandResearch Ethics Committee (LNRRECRef. No. 6659UHL).
After collection, assigning randomized identifiers anonymized the
blood and sperm samples. Lymphoblastoid cell line genomic
DNAs from 1 CEPH/FRENCH and 5 CEPH/UTAH pedigrees,
obtained from the Centre d’Etude du Polymorphisme Humain
(CEPH)/Fondation Jean Dausset were also utilized (Supp. Meth-
ods). Genomic DNA was isolated using the Gentra Puregene Blood
kit (Qiagen UK, Manchester, Lancs, UK) following the manufac-
turer’s instructions. DNA integrity was assessed by fractionation on
0.8%(w/v) agarose gels alongside intact bacteriophageλDNA.DNA
was visualized by ethidium bromide (0.5μg/ml) staining under UV
illumination.
TS-ATLAS
TS-ATLAS is a modification of ATLAS [Badge et al., 2003] that
uses transduction specificprimers to selectively amplify loci contain-
ing transduced sequences from oligonucleotide-linkered genomic
libraries. All oligonucleotides (Supp. Table S1) were HPLC purified
by the manufacturer (Sigma Aldrich UK, Gillingham, Dorset, UK)
and resuspended at 50 μM in 5 mM Tris–HCl, pH 7.5. All pre-PCR
reaction set up was carried out in a Class II laminar flow hood
(Walker Safety Cabinets, Glossop, Derbys., UK), decontaminated
by UV exposure for at least 30 min before use.
Library Construction and Amplification
The method described below is the VspI-specific protocol for the
L1RP transduction lineage (Supp. Methods Protocol 1 and Supp.
Fig. S1). Variations required for the MspI-specific L1RP transduc-
tion lineage assay and AC002980 and LRE3 lineages are described
in the Supp. Methods (Protocols 2–5 and Supp. Fig. S2–S4). Briefly,
600ngof genomicDNAwere digested to completionwith 20units of
VspI (Promega, Madison, WI) in the manufacturer’s recommended
buffer at 37◦C for 3 hr. After incubation, reactions were heated to
65◦C for 20 min to inactivate the restriction enzyme. Before set-
ting up the ligation reaction, linker oligonucleotides were freshly
annealed by mixing equal volumes of 20 μM RBMSL2 and RBD3,
heating to 65◦C for 10 min, and then cooling to room temperature.
An aliquot (100 ng) of the digested DNA was ligated to a 40-fold
molar excess of the annealed suppression linker (2.7 μl of 10 μM
annealed linker for VspI libraries) with 4 weiss units T4 DNA ligase
(Promega) in 1X Ligase Buffer (Invitrogen, Paisley, Renfrewshire,
UK) overnight (∼16 hr) at 15◦C, in a final volume of 20 μl. After
ligation, the reaction was heated to 70◦C for 10min to inactivate the
ligase. Excess linkers and short DNA fragments (i.e., <100 bp) were
removed with the Qiaquick PCR purification system (Qiagen) fol-
lowing the manufacturer’s protocol, but eluting the DNA in 30 μl
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5 mM Tris–HCl pH 7.5. In our hands, the purification is ∼80%
efficient, resulting in a purified library containing approximately
2.7 ng/μl of genomic DNA. Libraries are sensitive to freeze/thaw,
and so were aliquotted and stored frozen at –20◦C. An aliquot (1μl)
of ligated genomic DNA was amplified in 10 μl PCR reactions con-
taining 1× PCR buffer (45 mM Tris–HCl pH 8.8, 11 mMNH4SO4,
0.9mMMgCl2, 6.7mM β-mercaptoethanol, 113μg/ml BSA, 1mM
dNTPs), 1.25 μM RBX4 primer, 1.25 μM RB3PA1 primer, and
0.4 units Taq DNA polymerase (ABgene, Epsom, Kent, UK). Re-
actions were cycled in a Tetrad 2 Thermal Cycler (MJ Research,
Waltham, MA) using the following conditions: 96◦C –1 min; 30×
[96◦C –30 sec; 58◦C –30 sec; 72◦C –1 min]; 72◦C –10 min. Primary
suppression PCR reactions were diluted 1:50 in Single Molecule Di-
lution Diluent (SMDD: 5 mM Tris–HCl pH 7.5, 5 ng/μl sonicated
Escherichia coli genomic DNA), and 1 μl diluted PCR reaction was
added to 9 μl secondary PCR reactions containing 1× PCR buffer,
0.625 mMRBY1 primer (Linker specific), 0.625 mM 011TD1 (L1RP
transduction specific), and0.4unitsTaqDNApolymerase (ABgene).
Reactions were cycled in a Tetrad 2 Thermal Cycler (MJ Research)
using the following conditions: 96◦C –1 min; 30× [96◦C –30 sec;
58◦C –30 sec; 72◦C –1 min]; 72◦C –10 min.
Recovery and Analysis of TS-ATLAS Products
An aliquot (10 μl) of secondary TS-ATLAS PCR products was
fractionated on 2% Seakem LE (Cambrex, Rockland,ME) 0.5X TBE
agarose gels alongside the 100 bp ladder (NEB, Ipswich, MA) size
marker and visualized by ethidium bromide (0.5 μg/ml) staining.
Novel PCR products were excised from the gel and purified using
the Qiagen Minelute system (Qiagen) following the manufacturer’s
protocol, but eluting the DNA in 10 μl of 5 mM Tris–HCl pH 7.5.
PurifiedPCRproductsweredirectly sequencedwithABIBigDyeVer.
3.1 Ready Reaction, using 3.3 μM RBY1 as the primer. Sequencing
reactions were purified using Performa DTR spin columns (Edge
BioSystems, Gaithersburg, MD) and the sequencing data collected
using an ABI 3730 capillary sequencer by the PNACL core DNA
sequencing service (University of Leicester). The sequences of the
TS-ATLAS amplicons were imported into the CHROMAS sequence
viewer and the L1 3′ transduction flanking sequencesmapped to the
HGR using BLAT (http://genome.ucsc.edu) [Kent, 2002]. Accession
numbers of the DNA sequences encompassing the L1 insertion lo-
cations were verified using the National Center for Biotechnology
Information (NCBI) BLASTN program (http://www.ncbi.nih.gov)
[Altschul et al., 1990]. Recovered L1 elements that had previously
been reported [Beck et al., 2010; Boissinot et al., 2000; Goodier et al.,
2000; Myers et al., 2002] are listed in Supp. Table S2. Putative novel
insertions were named using the convention followed in Badge et al.
(2003) and Beck et al. (2010). The insertions were assigned to the
accession of the completely sequenced large insert clone (BAC/PAC)
containing the insertion empty site sequence, as represented in the
human genome reference sequence (hg18), and are listed in Table 1.
Primer Design for Novel L1 Insertions Related to RP,
AC002980, and LRE3
Upon identification of the insertion sites of novel L1s, flank-
ing DNA sequences were obtained from the HGR, the repeats
Table 1. TS-ATLAS and Related Loci
Family Presence Detected Location Chr Transduction Allele
Accession/L1 library in HGR in 1000G? (position) Length TSDs length (nt) frequencya
AL050308b RP-VspI – Y Xq27.2 (140342939, –) FL AAAAAGTTTTAAATTT 0 0.149
AC005888b RP-MspI – Y 12q24.31 (125221192, +) 5′Truncated AAAGAAATAAGG 11 Polymorphic
AC005939 RP + NA 17q24.3 (65966692, +) FL AAGATTTTGTG 10 0.327
AC093861 RP + NA 4p13 (44202069, –) 5′Truncated None detected 11 NT
AL590011c RP – N 6q13 (72856236, +) FL TAAGAAAATGTGGCACA 11 0.210c
AC019288c RP – Y 15q14 (33441423, –) FL AAAAAATGAAAATC 11 0.002c
RPd RP – NA Xp11.3 (46582227, +) FL AAGACTGTAAGGTG 11 Private
AL118519 2980-VspI + NA 6q13 (70776960, +) FL CAAAACAAAACAAAGCAAAC 0 Polymorphic
AC002980 2980-NlaIII + NA Xp22.2 (11869357, –) FL AAAAAAAATCACCA 174 0.495
AC010387 2980-VspI + NA 5p14.2 (24409194, –) 5′Truncated AAATTTTGTTTTA 222 Polymorphic
AC004740b,c 2980-NlaIII – Y 7p21.3 (8853240, +) FL AACAATATGTA 222 0.063c
AP001604b 2980-NlaIII – N 21q21.3 (27594286, –) 5′Truncated AGAAAGTGCCCTGTAG 222 0.056
AC048382b 2980-NlaIII – Y 15q25.2 (82941913, +) FL AAGATGTAAGTAGAAA 181 0.025
AP001029b,c 2980-NlaIII – Y 18p11.21 (12481262, +) FL AAGAAAATCCT 173 0.016c
AC069023b 2980-NlaIII – NA 10p12.33 Undetermined In Duplicon 174 NT
AC116311b 2980-VspI – N 5q21.1 (100553773, +) 5′Truncated AGAAATAATGTAA 406 0.037
AC010749b 2980-NlaIII – Y 7p21.1 (17061239, +) 5′Truncated TAAAACAATTGTTC 173 Polymorphic
LRE3/AC067958b,d LRE3-MseI – Y 2q24.1 (156236094, +) FL GAAAGAAAGAAAGAA 0 0.328
BX927359e LRE3-MseI – N 14q32.23 (104052295, +) FL AAAATGAAATAAAAT 257 0.016
AC091138e LRE3-MseI – N 18q22.3 (68673030, –) 5′Truncated GAAAGAATAAGATATTTTG 273 0.016
AC068286b LRE3-MseI – N 2p24.3 (14899793, +) FL AGAAATAAGTGTCTA 263 0.0
AL592182b LRE3-MseI – N 1p33 (50455323, +) FL AGAAAACAACAGAGGGG 263 0.0
AL031584b LRE3-MseI – N Xp11.3 (45671041, +) 5′Truncated AAATCAACCACAGAAAACAAACC 263 0.04
AL353685c LRE3 – N 9q31.1 (106675844, +) FL GAACAAGCCTGG 278 0.0c
CYBBd LRE3 – NA Xp11.4 (37538956, +) 5′Truncated AA 280 Private
aWhether an element was detected in our analysis of the 1000 Genomes dataset is recorded in column 4 as: Y = Yes, N = No, and NA = Not Analyzed (because the element is in the
HGR, private to an individual with a disease causing insertion or not mapped uniquely). Allele frequencies are listed in this study as determined in a panel of 129 unrelated CEPH
individuals, or when previously described [Beck et al., 2010] with their reported allele frequency. Loci discovered in one member of the blood donor panel, but absent from the
CEPH genotyping panel, are listed with allele frequencies of 0.0, as the relatedness between the donor panel and CEPH panel is not known. Loci are described as “polymorphic”
if they were not fully genotyped, but were present or absent in more than one individual in the blood donor or CEPH panels. Disease causing de novo insertions are described as
“Private”. FL = full length, NT = not tested.
bIdentified in blood donor panel (this study).
cDescribed in Beck et al. (2010).
dDescribed as disease causing insertions [Brouha et al., 2002; Kimberland et al., 1999].
eIdentified in CEPH panel (this study).
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were masked using RepeatMasker (http://www.repeatmasker.org/),
and PCR primers were designed using Primer 3 (http://frodo.
wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). Primers were de-
signed so that the 3′ flanking primer (downstream of the L1 poly
(A) tail) was 3′ of the restriction site to which the library linker
was ligated, which enabled independent verification of the ligation
point. Where flanking sequence was highly repetitive, primers were
positioned across the junction of repeats.
Verification of Novel L1s Containing 3′ Transductions
The presence of L1s preceding 3′ transductions related to RP,
AC002980, or LRE3 was verified by PCR amplification using a
unique 3′ flanking primer and the primer RP3PA2, which is specific
to the 3′ end of human-specific L1s. Primer sequences are listed in
Supp. Table S1. PCR products were separated on 2% agarose gels,
purified using the Qiagen Minelute system (Qiagen), cloned using
the pGEM-T easy kit (Promega), and transformed into ultra compe-
tentDH5α E. coli cells. PlasmidDNAwas recovered using aQIAprep
Spin miniprep kit (Qiagen). An aliquot (20–30 ng/kb) of plasmid
DNA was sequenced using the Big Dye Terminator v3.1 as above
with 3.3 μM sequencing primer (M13F or M13R) to determine the
insert sequence.
Length and 5′ TDSs of Novel L1 Loci
The length of novel L1 insertions was confirmed by amplifying
with a unique 5′ flanking primer and the primer RB5PA2 specific
to the 5′ end of a human specific L1s. Primer sequences are listed
in Supp. Table S1. Where novel L1 insertions appeared to be 5′
truncated such that no 5′ specific amplicon was produced, the entire
element was amplified using the unique 5′ and 3′ flanking DNA
primers. In principle, this strategy would enable amplification of
elements with 5′ inversions, but none were detected in this study.
TSDs and the L1 insertion site in the HGR were determined by
excising amplicons from 2% agarose gels, purifying the DNA using
the QiagenMinelute system (Qiagen), and directly sequencing with
ABI BigDye Ver. 3.1 ReadyReactions as described above, using the
flanking region primers.
Presence/Absence Polymorphism
Dimorphism of L1 insertions related to L1RP, AC002980, or LRE3
was determined using two PCR assays: the “filled” site reaction
amplified the 3′ end of the L1 and its 3′ flanking DNA, whereas the
“empty” site reaction amplified the DNA flanking the L1 insertion
point in the absence of the L1, as described previously [Badge et al.,
2003; Sheen et al., 2000]. A panel of unrelated Northern European
CEPH genomic DNAs (n = 129) was used to estimate L1 insertion
allele frequency. This subset was derived from unrelated individuals
(grandparents and parents) from CEPH families 02, 12, 17, 21, 23,
28, 35, 37, 45, 66, 102, 104, 884, 1331, 1332, 1333, 1340, 1341, 1344,
1345, 1346, 1347, 1349, 1350, 1362, 1375, 1377, 1408, 1413, 1416,
1418, 1420, 1421, 1423, 1424, 13291, 13292 and 13293. The primers
used are listed in Supp. Table S1.
Amplification and Sequencing of L1 AL050308
The full-length putative L1RP progenitor AL050308was amplified
using a 5′ primer positioned across the junction of the L1 and its
5′ flanking genomic DNA and a 3′ primer unique to the 3′ flanking
genomic DNA of AL050308 (primer sequences listed in Supp. Table
S1). An aliquot (40 ng) of sperm genomic DNA from a male donor
who is hemizygous for the AL050308 insertion was subjected to
long-range PCR amplification in 10 μl PCR reactions containing
1×PCRbuffer, 0.0625μMof each primer, and 0.05 units/μlTaq/Pfu
mixed in the ratio 10:1 (ABgene/Stratagene, Agilent Technologies,
SantaClara, CA). Reactionswere cycled in aTetrad 2ThermalCycler
(MJ Research) using the following conditions: 96◦C –1 min; 28×
[94◦C –15 sec; 68◦C –10 min]; 72◦C –10 min. PCR products were
separated on a 1% agarose gel and purified using a QIAquick gel
extraction kit (Qiagen). The PCR products were directly sequenced
using the flanking genomic primers and a set of L1 sequencing
primers designed to the L1.3 (L19088) reference sequence.
AL050308 Cloning and Retrotransposition Assays
L1 AL050308 was amplified from volunteer donor sperm gDNA
by long-range PCR using flanking genomic primers JM0308D and
CM0308A. To enable amplification of error-free PCR products,
long-range PCR using the Expand Long Range polymerase system
(Roche Applied Science, Burgess Hill, Sussex, UK) was employed
using 50 ng of template DNA and buffer 2. PCR products were
then cloned by digesting PCR fragments withAccI, performing PCR
clean up with the Zymoclean DNA gel recovery kit (Zymo Research,
Irvine, CA), and ligation of fragments into appropriate restriction
sites in the pBluescript-based vector pJCC9 containing the mneoI
retrotransposition indicator cassette [Beck et al., 2010]. Cloned L1RP
progenitor elements were sequenced in their entirety (∼4× cover-
age) to identify clones with minimal sequence variation from the
directly determined consensus.
Clones were tested for retrotransposition activity relative to L1.3
(accession L19088) alongside the retrotransposition defective neg-
ative control construct pJCC9 L1.3 D702A (RT-) as previously de-
scribed [Beck et al., 2010; Moran et al., 1996; Wei et al., 2000, 2001].
HeLa cells were cultured as previously described [Beck et al., 2010;
Moran et al., 1996]. Six-well tissue culture plates were seeded with
approximately 5× 103, 2× 104, or 2× 105 cells, and 24 hr later, three
wells of each cell concentrationwere transfectedwith 1μg of plasmid
using Fugene 6 transfection reagent (Roche) and Opti-mem media
(Gibco, Grand Island, NY). Approximately 18–24 hr posttransfec-
tion culture media was aspirated and replaced. Media was replaced
daily from 72 hr posttransfection with media plus 400μg/mL G418
(Gibco). Fourteen days after transfection, cells were washed, fixed,
and stained with 0.1% crystal violet as previously described [Beck
et al., 2010]. G418-resistant colonies were counted on the 5× 103 or
2× 104 plates. Transfection efficiencies were obtained using 2× 104
and 2 × 105 cells transfected with pCEP/GFP as per the transient
retrotransposition assay protocol [Beck et al., 2010; Moran et al.,
1996; Wei et al., 2000].
Screening for Transduction Lineage Elements Within the
1000 Genomes Pilot Data
Briefly, Roche 454-acquired genomic sequence data (from 375
individuals) from the 1000 Genomes Project Pilots 1–3 [2010]
were downloaded and filtered to exclude very short reads (<45 bp)
resulting in database of ∼1.6 billion reads. MegaBLAST [Zhang
et al., 2000] searches using genomic sequences flanking the insertion
points of novel TS-ATLAS-discovered elements were used to iden-
tify reads mapping to these loci. These reads were analyzed to find
junctions between genomicDNA and L1 or transduction sequences.
These junction reads were validated by realignment and manual in-
spection. The detailed computational procedure is described in the
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Supporting Information and reads supporting the presence of novel




We modified 3′ ATLAS [Badge et al., 2003] to selectively amplify
L1s with shared 3′ transduction sequences. These L1s were ampli-
fied from oligonucleotide-linkered genomic libraries in a method
termed TS-ATLAS. Figure 1A illustrates this procedure as devel-
oped for the L1RP transduction lineage, and is designed to equally
amplify all members of the lineage. Other lineages (AC002980 and
LRE3) required modifications that prevented the amplification of
common lineage members. For example, the efficient amplification
of AC002980 can outcompete novel lineage members with longer
transductions (detailed in the Supp. Methods, Protocols 3 and 4).
Briefly, genomic DNA was digested to completion with restric-
tion enzymes (Fig. 1A, diamond tipped lines) generating fragments
containing L1 termini and their immediate 3′ flanking genomic se-
quences. The digested DNA was then ligated to a GC-rich double
stranded ATLAS linker (Fig. 1A, AL) and suppression PCR was per-
formed using either an L1 3′ UTR or 3′ transduction specific primer
in conjunction with a linker specific primer. Intramolecular anneal-
ing of DNA fragments that have linkers attached to both ends leads
to the formation of stable “panhandle” structures that suppress PCR
amplification [Badge et al., 2003; Broude et al., 2001; Lavrentieva
et al., 1999]. This suppression is relieved if a 3′ UTR or transduction
specific primer anneals within the loop of the panhandle structure
and is extended by Taq DNA polymerase, generating an amplicon
with only one linkered end. The resultant amplicon then can serve
as an exponential amplification template. For the L1RP lineage, the
primary PCR utilized the L1 3′ UTR specific primer RB3PA1 and a
secondary nested PCR was employed to enrich for DNA fragments
containing the L1RP specific 3′ transduction (Fig. 1A, black arrow)
and its associated flanking DNA sequences. In the case of L1RP lin-
eage elements that are not the progenitor, (Fig. 1A, right panel) this
procedure generates fragments containing the L1RP transduction
sequence, upstream of a poly (A) tract and the 3′ genomic DNA
flanking the L1 insertion. In contrast a putative progenitor of the
L1RP insertionwould terminate in its poly (A) tail, and the 3′ flanking
sequence subsequently identified as a transduction in offspring ele-
ments. This “transduction” sequence will be followed by 3′ flanking
genomic DNA which does not contain a second poly (A) tract, en-
abling its identification as a putative progenitor. Notably, TS-ATLAS
amplification schemes also were developed for the 3′ transduction
sequences flanking AC002980 and LRE3 (Supp. Methods, Protocols
3–5). To validate the reproducibility of TS-ATLAS, three-generation
CEPH pedigrees showing segregation of AC002980 (CEPH families
12, 1333, 1340, 1424, and 1347) and LRE3 (CEPH families 1333,
1340, 1424, and 13291) were analyzed using lineage-specific TS-
ATLAS and insertion specific genotyping. In all cases, TS-ATLAS
amplification patterns were entirely concordant with the genotypes
of all familymembers (data not shown). The L1RP specific amplifica-
tion scheme was not applied to CEPH pedigrees as initial screening
of unrelated donors revealed only one novel amplicon (see below).
Discovery of a Putative RP Lineage Progenitor
Application of the L1RP lineage specific TS-ATLAS scheme to ge-
nomic DNA from a small panel of unrelated DNA donors (n = 9)
resulted in the recovery of a PCR product from one donor with a
sequence consistent with it being a progenitor of the L1RP lineage.
Subsequent genotyping of a panel of 129 unrelated CEPH DNAs
showed this progenitor was not rare (allele frequency = 0.149).
Long-range PCR and direct sequencing confirmed that the allele
from the original donor had intact open reading frames. Low-error
rate long-range PCR was used to amplify representative PCR prod-
ucts and these were cloned into a retrotransposition assay vector,
making use of conserved AccI sites at the element’s termini [Beck
et al., 2010; Sassaman et al., 1997]. Ten clones were sequenced at
∼fourfold coverage and assayed for retrotransposition activity. One
clone showed no nucleotide variation from the directly determined
sequence and retrotransposed at ∼170% the rate (n = 6) of a refer-
ence active L1 element (L1.3, L19088 [Dombroski et al., 1993]), as
illustrated in Figure 1B.
Analyses of the above data, searches of sequence databases, and
identification of L1RP lineage members from the literature suggest
that the L1RP transduction family is composedof at least sevenmem-
bers (Table 1, and Fig. 2A). AC005939 and AC093861 are present
in the human genome reference (HGR) sequence [Myers et al.,
2002], whereas AL050308 and AC005888 were discovered in this
study.TwoL1RP-related full-lengthpolymorphicL1s (AL059011and
AC019288) were previously detected using a fosmid-based, paired-
end DNA sequencing strategy [Beck et al., 2010]. In summary, the
L1RP transduction family contains the private mutagenic insertion
L1RP, its likely progenitor (AL050308), at least three additional poly-
morphic full-length elements (AC005939, AL059011, AC019288),
and two 5′ truncated L1s (AC005888, AC093861), whose allele fre-
quencies range from 0.002 to 0.210.
TS-ATLAS with Common Allele Suppression
NextwedevelopedTS-ATLAS schemes for twoother disease caus-
ing lineages, AC002980 and LRE3 [Brouha et al., 2002; Myers et al.,
2002]. Unlike the L1RP lineage,members of these families are known
to be common within human populations [Brouha et al., 2002;
SelemeMdel et al., 2006]. As suppressionPCR is competitive, ampli-
fication of a common insertion potentially jeopardises amplification
of novel elements with longer transductions or with restriction sites
(for linker addition) distant from the L1. To overcome this techni-
cal hurdle, we suppressed amplification of known common lineage
members by digesting the linkered libraries with a rare cutting re-
striction enzyme predicted to cut between the end of the transduced
sequence and the flanking linker ligated restriction site. In the case
of L1 AC002980 this was MunI, as illustrated in Figure 3A. Lack
of MunI digestion allowed amplification only of AC002980 itself
(Fig. 3B, lane 16), whereas libraries derived from our nine gDNA
donors, pre-digested withMunI, yielded a constellation of potential
AC002980 family members (Fig. 3B, lanes 1–9).
L1 Transduction Family: AC002980
TS-ATLAS identified 10 elements with transductions consistent
with theAC002980 lineage. Three elementswere present in theHGR
(AC002980, AL118519, AC010387), including the putative lineage
progenitor AL118519 and a related L1, AC010387 (Table 1). We
identified seven other L1s that share the AC002980 3′ transduction,
two of which, AC004740 and AP001029, were previously detected
by fosmid end sequencing [Beck et al., 2010]. Five of the L1s were
full-length and four were 5′ truncated, and all contained discernable
TSDs (Table 1, and Fig. 4A). Also nine of the 10 L1s in the AC002980
lineage were dimorphic with respect to presence/absence, with
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Figure 1. See figure legend on next page.
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Figure 1. Schematic of RP-specific TS-ATLAS and activity of L1 AL050308. A: TS-ATLAS using a primer specific to the RP transduction shown
on the right is an offspring L1 (red rectangle, labeled “L1 RP”) of a progenitor L1 (red rectangle to the left, labeled “L1 Hs”), which carries two
poly (A) tails (A(n).) These poly (A) tails are separated by a short transduced sequence consisting of the progenitor’s TDS sequence (red chevron),
and flanked by distinct TSDs (light blue chevrons). PCR reactions containing linker specific (black arrow, labeled “AL”) and transduction specific
primers (black arrow, labeledwith RP transduction sequence) and using linkered genomic DNA libraries as a template enable specific amplification
of both types of element. Offspring elements are identifiable by the presence of a poly (A) tail downstream of the transduction sequence (red
chevron), whereas progenitor elements lack this. Sequencing of transduction PCR products enables their 3′ flanking genomic DNA to be used to
determine if they originate from novel insertions. B: Retrotransposition of Putative Lineage Progenitor L1 AL050308 TS-ATLAS was used to identify
a putative novel progenitor for the RP lineage, inserted into genomic accession AL050308. The three panels show the results of representative
duplicate cell culture based retrotransposition assays using L1 elements cloned into standard assay vectors. L1.3 (Accession L10988) is a reference
element: its ability to generate G418 resistant HeLa cell colonies (left panel) was compared with that of the putative L1RP progenitor, AL050308
(right panel). This clone of the AL050308 element has no nucleotide changes from the genomic consensus sequence of the L1, and retrotransposes
at ∼170% the rate of L1.3 (n = 6). As a negative control an L1 construct with an inactivating mutation in the RT domain of ORF2p in L1.3 [Wei et al.,
2001, 2000] was assayed under the same conditions (middle panel, RT-).
allele frequencies ranging from 0.016 to 0.485 (Table 1). The tenth
AC002980 member (AC069023) was embedded in a segmental du-
plication and thus, was intractable for genotyping and determina-
tion of L1 length (Table 1). Two additional members (ABC9 21 and
ABC13 100) of the AC002980 family identified previously [Beck
et al., 2010] were not detected in our panel using TS-ATLAS, likely
due to the small number of individuals screened (n = 9).
L1 Transduction Family: LRE3
TS-ATLAS revealed five novel L1 insertions that share the 3′ trans-
duction flanking the likely progenitor of a disease-producing in-
sertion into the CYBB gene (MIM #300481), LRE3 ([Brouha et al.,
2002], Table 1, andFig. 2B). Three insertions, BX927359,AC068286,
and AL592182 are full-length and represent potentially active L1s.
Two of these, AC068286 and AL592182, appear to be rare as they
were absent from the CEPH genotyping panel of 129 unrelated
individuals. As these LRE3 lineage insertions occurred in a single
donor also carrying the LRE3 progenitor element (AC067958) the
sequence of themicrosatellite region of the progenitor and offspring
was compared with determine whether the progenitor had directly
given rise to the novel element, as described previously [van den
Hurk et al., 2007]. In both cases, at least two independent changes
(microsatellite repeat number and substitutions) were observed be-
tween the progenitor allele and putative offspring elements (data
not shown). Given the high error rate of the L1 RT [Gilbert et al.,
2005] and the established instability of the LRE3microsatellite [van
den Hurk et al., 2007] we cannot absolutely exclude a direct descent
relationship, but together these changes make this seem unlikely in
these cases. L1s BX927359 and the 5′ truncated AC091138 are both
present at a very low allele frequency of 0.016. The 5′ truncated el-
ement AL031584 is located on the X chromosome and has an allele
frequency of 0.04. In summary, the LRE3 family appears to be the
youngest transduction family examined by TS-ATLAS: 87.5% (7 of
8 tested) of its member L1s (including the CYBB disease causing
insertion) are rare (present in only one individual) or at low allele
frequencies (allele frequency < 0.04) within the human population
analyzed [Beck et al., 2010; Brouha et al., 2002].
Variable Polyadenylation of AC002980 Lineage Members
Inspection of the 3′ transduction sequences of the AC002980
lineage revealed evidence for alternative polyadenylation. In
some cases, polyadenylation occurred within the 3′ transduction
sequence. The most parsimonious explanation of these data is that
the putative progenitor of this transduction family, AL118519, gave
rise to three sublineages with long, intermediate, or short transduc-
tions (Fig. 4A). Long transduction elements (insertions AC004740
and AC010387) likely utilize a predicted poly (A) site (highlighted
in red in Fig. 4B) located 200 nts downstream of the native L1 poly
(A) site. The singlemember of the intermediate transduction length
sub-lineage, AC048382 (Fig. 4B, top alignment section and Supp.
Fig. S5), likely utilized a predicted poly (A) site located 153 nu-
cleotides downstream of the native L1 poly (A) site, but generated
a transduction derived from AL118519, which is 41 nucleotides
shorter than the long transductions. This transduction is 7–8 bp
longer than the short transduction elements, which could equally
be accounted for by variation in the reverse transcription initiation
site, or variation in the position of the poly (A) addition site.
The four members of the short sub-lineage, AP001029,
AC010749, AC069023, and AC002980 are polyadenylated within
one nucleotide of each other, and likely use the same polyadeny-
lation signal as the intermediate length L1 AC048382 (Fig. 4B, top
alignment section and Supp. Fig. S5). Finally the ‘hot’ prototype
element of this lineage, AC002980, has given rise to a lineage that
includes two 5′ truncated elements that share sequences flanking
the 3′ end of the 3′ TSD; these L1s also have different poly (A) tail
lengths (Fig. 4A and B and Supp. Fig. S5). Insertion AC116311 ap-
parently used a predicted poly (A) site 378 nucleotides downstream
of the native AC002980 poly (A) site, whereas AP001604 apparently
used a predicted poly (A) site 193 nucleotides downstream of the
native L1 poly (A) site. Together, these data suggest that although
the presence of a poly (A) tail is critical for retrotransposition, the
usage of particular poly (A) sites is highly variable and apparently
local sequence context dependent, explaining why many L1s are
flanked by 3′ transduced sequences. However, the L1RP and LRE3
lineage members analyzed here show stable poly (A) site utilization
(Supp. Fig. S6 and S7), so this phenomenon could be peculiar to the
AC002980 lineage.
Screening the 1000 Genomes Pilot Data for Novel
TS-ATLAS Identified L1 Insertions
Notably, none of the novel elements reported here was recov-
ered in the 1016 novel insertions reported by Ewing and Kazazian’s
analyses of the pilot 1000 Genomes Project dataset [Ewing and
Kazazian, 2011]. This may be a result of the difficulty of un-
ambiguously mapping NGS-generated short reads derived from
transduced sequences which are, by definition, not single copy.
Additionally, the lack of identification of transduction-containing
elements could be due to the low sequence coverage of the pilot data.
To distinguish these possibilities, we screened the 1000 Genomes
data for junction reads that corresponded to the sequences of TS-
ATLAS identified novel (i.e., absent from the HGR) insertions. This
revealed that eight of 18 nonreference insertions (excluding L1RP
and L1CYBB) were supported by junction reads (Table 1), indicating
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Figure 2. L1 transduction families data presented in Figure 3 are compiled from this and other studies [Beck et al., 2010; Brouha et al.,
2002; Goodier et al., 2000; Kimberland et al., 1999; Myers et al., 2002]. Ideograms were adapted from the NCBI map viewer Website
(http://www.ncbi.nlm.nih.gov/projects/mapview/). A: Transduction family RP. The RP family is characterized by a transduction putatively de-
rived from the L1 locus AL050308. AL050308, AL590011, AC005939, AL019288, and L1RP are full length and AC005888 is 5′ truncated. L1RP is a disease
causing insertion [Kimberland et al., 1999]. Asterisks (∗) denote L1s present in the human genome reference assembly (hg18). Insertion AC093861
is not included as the absence of TSDs (see Table 1) means we cannot exclude a non-TPRT mechanism for its mobilization. B: Transduction family
LRE3. The LRE3 family is characterized by a transduction originally derived from the L1 locus LRE3. LRE3, BX927359, AC068286, AL592182, and
AL353685 are full length. AC091138 and AL031584 are 5′ truncated. L1CYBB is a disease causing insertion [Meischl et al., 2000].
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Figure 3. Schematic representation of TS-ATLAS with common
allele suppression. A: Amplification of L1 AC002980 is prevented by
digestion with MunI. A commonly known transduction family member
(upper panel, blue rectangle, labeled “L1Hs AC002980”) carries a lin-
eage specific transduction (red line and chevron) and is flanked by
distinct TSDs (light blue chevrons). L1 AC002980 competes with the
amplification of novel lineage members. By selecting a rare restriction
site (MunI) in the 3′ flanking DNA of this element, upstream of the NlaIII
linker site, pre-digestionof linkeredgenomic libraries suppresses its am-
plification. Novel lineage members directly derived from L1 AC002980
carry the lineage specific transduction (red line and chevron) and a
second transduction (light blue line and chevron) and are flanked by
distinct TSDs (black chevron). Novel members most likely lack the com-
bination of the rare cutting (MunI) restriction enzyme upstream of a
very common NlaIII site, and so their amplification is not suppressed.
B: Representative TS-ATLAS display gel showing the results of applying
the AC002980-specific (NlaIII) assay. Lanes 1–9 show display patterns
of nine unrelated individuals each of whom carries the AC002980 L1.
Control reactions in lanes 11, 13, 14, and 16 were setup using the same
library sample as is shown in Lane 9. Lane 16 shows the amplification of
theAC002980 locus,which is suppressed by digestionwithMunI in lanes
1–9. Lanes 2, 7, and 9 show amplification of the AC004740 locus. Lane
3 shows amplification of the AP001604 locus. Lane 6 shows amplifica-
tion of the AC048382 locus. Lane 7 shows amplification of the AC069023
locus. Lane 8 shows amplification of the AP001029 locus. Lane 10—
Reaction in the absence of genomic DNA. Lane 11—Reaction in the
absence of restriction enzyme (NlaIII). Lane 12—Reaction in the ab-
sence of genomic DNA. Lane 13—Reaction in the absence of T4 Ligase.
Lane 14—Reactions in the absence of linker. Lane 15—Reaction in the
absenceof digestedgenomicDNA. Lane16—Reaction in theabsenceof
supression enzyme digestion (MunI). Lane 17—Control for primary PCR
with DNA omitted. Lane 18—Control for secondary PCR with DNA omit-
ted. MW—molecular weight marker (100 bp ladder [NEB]). All labeled
bands were sequenced to verify their origin.
that their novelty is not due to low genome sequencing coverage.
The eight insertions identified (AL050308, AC005888, AC019288,
AC004740, AC048382, AC010749, AP001029, and AC067958) have
a range of allele frequencies, from 0.002 to 0.328, demonstrating the
1000 Genomes dataset’s ability to capture both common and rare
insertions.
Discussion
The 3′ transduction of genomic sequences by L1 is a relatively
common event. For example, there are at least five instances where
L1s carrying 3′ transductions have disrupted human genes: APC
(MIM #611731) [Miki et al., 1992]; Dystrophin, DMD (MIM
#300377) [Holmes et al., 1994], CYBB (MIM #300481) [Meischl
et al., 2000]; RP2 (MIM #300757) [Schwahn et al., 1998]; and CHM
(MIM #300390) [van den Hurk et al., 2003, 2007]. Here, TS-ATLAS
was combined with previously published data [Beck et al., 2010;
Brouha et al., 2002; Goodier et al., 2000; Kimberland et al., 1999;
Myers et al., 2002] to enable the identification of 25 L1s from three
active L1 transduction lineages (L1RP, AC002980, and LRE3). On
genotyping the novel elements revealed by TS-ATLAS, we noted
that none of the elements reported here was recovered in the study
by Ewing and Kazazian analyzing the pilot 1000 Genomes Project
dataset [Ewing and Kazazian, 2011], despite some overlap between
the study participants and our genotyping panel. Screening the 1000
Genomes data for junction reads that corresponded to the sequences
of TS-ATLAS-identified insertions (Supp. Table S3), revealed eight
of 18 insertions were supported by junction reads, indicating that
their novelty is not due to low genome coverage in the pilot data.
Thus, without lineage-specific molecular genomic approaches, cap-
turing L1 transduction lineages in genome sequencing data will
require refinement of existing bioinformatic approaches.
These results demonstrate that adapting transposon display
methods is an effective means to selectively analyze active L1 lin-
eages. Additionally, for some loci, the use of frequently cutting
restriction enzymes can enable more comprehensive coverage of
the human genome, allowing for the identification of more lineage
members. For example, whole genome in silico restriction analyses
showed that only ∼12% of the genome is within suppression PCR
range (<∼1,000 bp) when libraries are constructed with VspI, but
that ∼80% of the genome is accessible using NlaIII. The relatively
small number of coamplifying fragments generated in TS-ATLAS
makes fractionation and isolation of novel loci by agarose gel elec-
trophoresis straightforward. In principle, TS-ATLAS could be en-
hanced by the use of multiple restriction enzymes (dependent upon
the particular transduction sequence), as used in a related display
technique developed to analyze LTR retrotransposons in the mouse
genome [Ray et al., 2011].
The application of TS-ATLAS to a small panel of nine unrelated
individuals allowed the identification of 20 novel L1s. Strikingly
the majority (11) of these elements were full-length raising the
possibility that these lineages are not only adept at propagating 3′
transductions but also generating full-length insertions. To estimate
the rate of full-length offspring element production across the three
lineages,we excludedputative progenitor elements that are necessar-
ily full-length (AL050308, AL118519, AC067958, and AC002980),
as well as disease causing elements that may be more likely to be
full-length due to acquisition bias (L1RP and L1CYBB), and elements
of unknown length (AC069023). This results in 59% (10 of 17) of
novel elements observed here being full-length, a stark contrast with
the∼30% of genomic Ta elements that are of similar size [Boissinot
et al., 2000]. However, it is very likely that full-length insertions are
selected against [Boissinot et al., 2001], leading to a reduction in
average insert length over evolutionary time. To test whether the
high fraction of full-length elements in transducing lineages is an
intrinsic property of these elements or simply reflects their evolu-
tionary young age could be tested using comparative quantitative
retrotransposition assays of the progenitor elements, as carried out
for L1RP and LRE3 previously [Farley et al., 2004; Gilbert et al.,
2005].
Of these 20 L1s, one (AL050308) is the putative progenitor of a
mutagenic insertion (L1RP) into the X-linked retinitis pigmentosa
RP2 gene [Schwahn et al., 1998] and retrotransposes at ∼170% of
the level of a ‘hot’ reference element, L1.3 (L19088 [Dombroski
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Figure 4. Variable transduction lengths in the AC002980 family. A: Characteristics and putative relationships of the AC002980 family. Data
presented here are compiled from this study and other publications [Beck et al., 2010; Brouha et al., 2002; Goodier et al., 2000; Kimberland
et al., 1999; Myers et al., 2002]. Putative relationships of L1 loci are indicated by arrows. Ideograms were adapted from the NCBI map viewer
(http://www.ncbi.nlm.nih.gov/projects/mapview/). The AC002980 family contains elements characterized by alternative polyadenylation resulting
in variable lengths of transduced sequence. The long, intermediate, and short transductions are derived from the progenitor locus AL118519.
Loci AC004740 and AC010387 retain the long transduction, AC048382 contains an intermediate length transduction, whereas AP001029, AC010749,
AC068023, and AC002980 have a shorter transduction. AP001604 and AC116311 contain sequences putatively derived from the AC002980 locus.
Asterisks (∗) denote L1s present in the human genome reference assembly (hg18). B: Multiple alignment showing variable transduction lengths and
putative polyadenylation sites in the AC002980 lineage. Dots represent identical nucleotides and dashes are gaps in the alignment. The alignment
begins 144 bp downstream from the start of the transduced sequence. Initially the alignment (bases 144–222) is against the 3′ flanking sequence
of the progenitor locus AL118519, starting within the transduced region and showing transduction length variants derived from locus AL118519.
Short transduction lengths end at bases 173/174, The intermediate transduction of AC048382 ends at base 181, and long transduction lengths end
at base 222. Following this (bases 198–405) the alignment shows the direct offspring of the AC002980 locus, with AP001604 ending at base 218
and AC116311 base 405. Sections highlighted in red are predicted poly (A) signal regions determined using the Hamming–Clustering (HC) network
analysis (http://zeus2.itb.cnr.it/∼webgene/wwwHC_poly(A).html). TSDs, confirmed by sequencing, are highlighted in blue.
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et al., 1993]). The allele frequency (0.149) and activity of AL050308
suggest that the L1RP lineage is actively amplifying in human popu-
lations. Previously reportedmembers of the L1RP lineage (AL590011
and AC019288, Table 1) show activities (∼69% and∼120%, respec-
tively, compared with L1.3) and allele frequencies (0.21 and 0.002,
respectively) consistent with this hypothesis [Beck et al., 2010].
Comparison of L1s from the AC002980 transduction lineage
revealed diversity in the site of L1 polyadenlyation. Of the 9 L1s
related to the progenitor element, AL118519, two pairs
of events used precisely the same poly (A) addition site
(AC010378/AC004740, AC010749/AP001029) but the five other
sites were used only once. Thus, nine events utilized seven distinct
poly (A) addition sites. These data are consistent with the notion
that L1 polyadenylation is dependent upon local primary sequence
context andcanoccur either at its native site or at suitable sites down-
stream of the L1 insertion. Indeed, these data are consistent with the
observation of serial transductions, where sequences from multiple
loci are sequentially mobilized by a particular L1 lineage [Brouha
et al., 2002; Goodier et al., 2000; Holmes et al., 1994; Pickeral et al.,
2000; van den Hurk et al., 2003]. Such events are well described in
the case of the LRE3 lineage and are also apparent in AC002980 and
L1RP lineages [Beck et al., 2010]. A consequence of a highly vari-
able, stochastic polyadenylationmechanism is that L1 3′ endsmight
be expected to expand rapidly over evolution, eventually leading
to the decay of the canonical Cleavage Polyadenylation Stimulating
Factor 1 (CPSF1) binding site upstream of the encoded poly (A)
tract. However, experimental observations suggest that the priming
of Target-Primed Reverse Transcription (TPRT) in L1 retrotranspo-
sition is not strictly dependent upon a terminally located adenosine
nucleotide, but can occur at internal sites in the L1 poly (A) tail
[Kopera et al., 2011; Kulpa and Moran, 2006; Ovchinnikov et al.,
2001]. As a result, in principle, TPRT could initiate within other
poly (A) tracts, such as the “original” terminal poly (A) tract, up-
stream of transduced sequences, a process that has been observed
for Alu constructs in cell culture assays [Wagstaff et al., 2012]. Such
priming events would lead to loss of the transduced sequences that
distinguish the lineage. A closely related group of three elements
that may exemplify this process is transduction lineage IV (c.f. Fig.
5 Beck et al. 2010 [Beck et al., 2010]). Two elements (ABC11 27 and
ABC11 35) share a short 3′ transduction, which the third element
lacks (ABC11 8). As the 3′ transduction in this lineage does not
include the TSD of ABC11 8, we can exclude the possibility that
ABC11 8 is the progenitor of ABC11 27 and ABC11 35. Another
possibility is that all three elements derive from the same progenitor,
but ABC11 8 has been polyadenylated at the canonical L1 CPSF1
binding site, removing the transduced sequence. Thus, populations
of L1 elements, some carrying 3′ transductions and some with a
canonical structure, might be maintained at equilibrium by these
opposing processes. A theoretical consequence of such equilibrium
would be a systematic underestimation of the number of elements
belonging to particular active L1 lineages, even when applying tech-
nical innovations such as TS-ATLAS.
By selectively amplifying related active L1 elements only, we can
simultaneously reduce the complexity of linkered PCR libraries and
so increase their sensitivity. With effective destruction of known
transduction primer targets by enzymatic suppression, the possi-
bility of amplifying fragments present at less than constitutional
levels arises. We are currently applying variants of these techniques
to germline (sperm) and fetal DNA pools to detect germline and
somatic mosaicism. Such mosaicism is likely to be common if en-
dogenous elements retrotranspose in early embryogenesis [Garcia-
Perez et al., 2007; Kano et al., 2009; van den Hurk et al., 2007].
Moreover, three highly active transduction-containing L1s are asso-
ciated with additional events, indicating they are donor ‘hotspots’
and have been active in modern human genomes [Beck et al., 2010;
Kidd et al., 2010]. Phylogenetic analysis of novel, active L1 elements
detected by fosmid end sequencing also captured additional trans-
duction lineages [Beck et al., 2010]. Thus, application of TS-ATLAS
to additional transduction families, and the use of this method
within larger pedigrees will directly provide data on the activity
of L1 lineages in the human population. Furthermore, as certain
transduction lineages include some of themost active L1s in human
populations, TS-ATLAS could be adapted to screen distinct cellular
populations for elements that have retrotransposed in a tissue spe-
cific manner. Brain regions where endogenous L1 activity appears
to be elevated [Baillie et al., 2011; Coufal et al., 2009; Muotri et al.,
2005; Muotri et al., 2010] could be illuminating targets.
In conclusion, by utilizing 3′ transduction sequences specific for
active lineages it is possible to efficiently capture related active L1s.
In addition, TS-ATLAS is flexible and can be readily adapted to
analyze different lineages of interest. One unexpected discovery en-
abled by TS-ATLAS is the apparent plasticity of the polyadenylation
location within a transduction family. Therefore, TS-ATLAS both
readily identifies amplifying lineages of L1 across multiple individ-
uals and provides novel insights into the mechanism of endogenous
L1 retrotransposition.
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